Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 10, Issue 1, Pages 226
Publisher
Springer Nature
Online
2012-11-19
DOI
10.1186/1479-5876-10-226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
- (2012) Douglas G Altman et al. BMC Medicine
- The connectivity of lymphogenous and hematogenous tumor cell dissemination: biological insights and clinical implications
- (2012) Jonathan P. Sleeman et al. CLINICAL & EXPERIMENTAL METASTASIS
- Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
- (2012) Linda Sofie Lindström et al. JOURNAL OF CLINICAL ONCOLOGY
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- To Biopsy or Not to Biopsy: Is That the Only Question?
- (2012) S. Dawood et al. ONCOLOGIST
- Molecular Alterations Between the Primary Breast Cancer and the Subsequent Locoregional/Metastatic Tumor
- (2012) R. Macfarlane et al. ONCOLOGIST
- Epithelial-Mesenchymal Transition: A Hallmark in Metastasis Formation Linking Circulating Tumor Cells and Cancer Stem Cells
- (2012) Magdalena Ksiazkiewicz et al. PATHOBIOLOGY
- Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy
- (2012) C. P. El-Haibi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Concepts of metastasis in flux: The stromal progression model
- (2012) Jonathan P. Sleeman et al. SEMINARS IN CANCER BIOLOGY
- Transcription factors zeb1, twist and snai1 in breast carcinoma
- (2011) Ylermi Soini et al. BMC CANCER
- HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis
- (2011) Nehmat Houssami et al. BREAST CANCER RESEARCH AND TREATMENT
- Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor–positive early breast cancer patients
- (2011) Johanna G. H. van Nes et al. BREAST CANCER RESEARCH AND TREATMENT
- ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer
- (2011) Jeanette Dupont Jensen et al. BREAST CANCER RESEARCH AND TREATMENT
- Positive lymph nodes do not metastasize
- (2011) Jutta Engel et al. CANCER AND METASTASIS REVIEWS
- Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors
- (2011) Naoki Niikura et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
- (2011) Eitan Amir et al. JOURNAL OF CLINICAL ONCOLOGY
- Understanding tumor heterogeneity as functional compartments - superorganisms revisited
- (2011) Thomas GP Grunewald et al. Journal of Translational Medicine
- A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer
- (2011) A Bonnomet et al. ONCOGENE
- Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis
- (2011) Reiki Nishimura et al. World Journal of Surgical Oncology
- CD73 Expression as a Potential Marker of Good Prognosis in Breast Carcinoma
- (2011) Anna Supernat et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort?☆
- (2010) Núria Montserrat et al. HUMAN PATHOLOGY
- Genome remodelling in a basal-like breast cancer metastasis and xenograft
- (2010) Li Ding et al. NATURE
- Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis
- (2010) L. Pusztai et al. ONCOLOGIST
- Does Analysis of Biomarkers in Tumor Cells in Lymph Node Metastases Give Additional Prognostic Information in Primary Breast Cancer?
- (2010) Anna-Karin Falck et al. WORLD JOURNAL OF SURGERY
- Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
- (2009) S. J. Aitken et al. ANNALS OF ONCOLOGY
- Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer
- (2009) C. Liedtke et al. ANNALS OF ONCOLOGY
- Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
- (2009) C. Simmons et al. ANNALS OF ONCOLOGY
- Expression analysis of E-cadherin, Slug and GSK3β in invasive ductal carcinoma of breast
- (2009) Chandra P Prasad et al. BMC CANCER
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
- (2009) S. A. Bustin et al. CLINICAL CHEMISTRY
- Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma
- (2009) Min A Kim et al. HISTOPATHOLOGY
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front
- (2008) Olivier Wever et al. HISTOCHEMISTRY AND CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More